Category: 23andMes
-
23andMe’s future prompts more worries, as genomic data analysis improves
•
Clients of genetic data company 23andMe may be at greater risk than they realize, notes A New York Times story This argues that the company’s problems could be short-term compared to the long-term threats facing its roughly 15 million people if 23andMe cannot continue as a going concern. Certainly, founder…